Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.
about
Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaPolyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense.Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteriaManagement of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic SocietyClinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteriaAntimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate Alamar Blue assayRecurrent catheter-related infection caused by a single clone of Mycobacterium chelonae with two colonial morphotypes.Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infectionsMultisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitumHigh prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Evaluation of Etest for susceptibility testing of rapidly growing mycobacteriaIn vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea.Catheter-related bloodstream infection caused by Mycobacterium brumaeSequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system.Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks.Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria.Cardiac device infections due to Mycobacterium fortuitum.An immunocompromised dialysis patient with skin and bone lesions.Mycobacterium tuberculosis pyomyositis in an infant.In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.Mycobacterium fortuitum: an iatrogenic cause of soft tissue infection in surgery.High levels of intrinsic tetracycline resistance in Mycobacterium abscessus is conferred by a tetracycline- modifying monooxygenase.
P2860
Q22241907-8DD48CF3-446A-4C1F-BE6C-0A123D46089FQ24535187-7D22E4BC-D79A-470C-A8AC-B713047C52C7Q24535651-6D762DCF-7009-4745-BB18-1FB8037FE83DQ24679338-51CD81D0-2BC2-474A-9942-DB9274DFE4BEQ28278933-1BB65E5D-BF9B-408C-885E-8A9761DC8216Q28538099-9EA20890-0DD9-4A98-9725-0FA24E910462Q33667274-611F6703-AEA5-4902-AEF5-CBA06DF2FA08Q33746042-5A9BC37E-457C-4C56-ACDA-0FA642EC3DB2Q33960674-CBC82D2C-09EB-45D9-8B79-2CBAA95744D5Q33965384-279782A2-0170-409E-B244-988E360F705EQ35014132-B386B569-1099-490A-A5BB-68924EEA5649Q35779935-4156A897-3A1B-49CF-AD94-F8D3782FA49AQ35843595-BDC2E963-44D8-4781-BF35-F502958AA3FDQ36156072-3C150C53-3D95-4CD4-90ED-58DD25E3CF46Q36523174-602F1A6E-5081-4C5A-B9E9-358E0529E6C2Q36854356-CD2B7F44-C0ED-46D1-BBF5-279A870BD711Q37597416-A3406367-199E-4DE8-980D-EDC474ED069DQ39468032-2B2B357A-237D-496D-8CEB-80E50593B26EQ39702587-1C4E6336-44A7-4908-A956-8CD89E1A85BBQ40015034-EB01C4D5-54DD-4C96-9759-1D5B95DC8A23Q40494955-C92A9519-F31C-4E7D-AA62-154DED4718FBQ40670499-2079ADEB-2169-4DC0-9381-EB954E11EC63Q41086553-3C5D60E1-F39B-40FB-A7C3-3E25CD7562C6Q41828834-A14F4528-FFC1-49B1-BBFE-7CE42135A293Q42763982-82A6E783-9050-498D-9B0F-DEE0628BF0F2Q45021417-26FAC83E-3A40-4E2B-956B-E34BAA2B290EQ52597956-79E17A58-D91A-417D-9F27-B2485F09A791
P2860
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Susceptibilities of Mycobacter ...... d amoxicillin-clavulanic acid.
@en
type
label
Susceptibilities of Mycobacter ...... d amoxicillin-clavulanic acid.
@en
prefLabel
Susceptibilities of Mycobacter ...... d amoxicillin-clavulanic acid.
@en
P2093
P2860
P356
P1476
Susceptibilities of Mycobacter ...... d amoxicillin-clavulanic acid.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.4.773
P407
P577
1991-04-01T00:00:00Z